The 4-day meeting was filled with exciting Oral Presentations, PosterPresentations, Award Lectures and Plenary Sessions that offered the unique opportunity to share ideas and participate in the interactive discussions and great debates on various aspects of hypertensive disease and cardiovascular protection.
Interviews – interviews with ESH Leadership
Teaching Seminars – focusing on problems in hypertensive patients seen in daily practice in an excellent educational format with many take-home messages.
Satellite Symposia – coverage of the Satellite Symposium presented during ESH 2017.
Meeting Abstracts – the ESH 2017 Meeting Abstracts of Posters and Oral Sessions from the Journal of Hypertension are now available!
The Official Hypertension Highlights from the 27th European Meeting on Hypertension and Cardiovascular Protection
The Best of ESH Meeting highlights. the The presentations and discussions chosen reflect the foremost research and strategies in hypertension that will directly impact patient care. Expert faculty place abstract findings into clinical context and discuss how the results may change the current standard of care.
JOINT SESSION
ESH (European Society of Hypertension) – ESC (European Society of Cardiology)
Atrial Fibrillation in Hypertension: cause and consequence
- Mechanisms of development of atrial fibrillation in hypertension
T. Kahan (Stockhom, Sweden) - Atrial fibrillation should be considered a hypertensive heart disease
M. Böhm (Homburg/Saar, Germany) - Best treatment in hypertension to prevent atrial fibrillation
E. Agabiti Rosei (Brescia, Italy) - Prevention of atrial fibrillation complications
A.J. Manolis (Athens, Greece)
TOPICAL WORKSHOP ON HOT ISSUES – SESSION 1
- BP, metabolic and neural consequences of bariatric surgery
G. Grassi (Milan, Italy)
PLENARY SESSION
- Salt: ESH/WFH document
M.J. O’Donnell (Galway/Hamilton, Ireland) - Worldwide trends in blood pressure: 1975-2015
B. Zhou (London, United Kingdom)
TOPICAL WORKSHOP ON HOT ISSUES – SESSION 2
- Systolic hypertension in the youth
E. Lurbe (Valencia, Spain)
PLENARY SESSION
- Seven decades of hypertension research and education in Ann Arbor, Michigan
S. Julius (Ann Arbor, MI, USA) - Björn Folkow Award Lecture
X. Jeunemaitre (Paris, France) - Presidential Lecture
Assessment of cardiovascular damage in hypertension
E. Agabiti Rosei (Brescia, Italy)
JOINT SESSION
ESH (European Society of Hypertension) – EASD (European Association for the Study of Diabetes)
Risk factor control in type 2 diabetes. An update 2017
- Treatment of hypertension in diabetes
G. Mancia (Milan, Italy)
PLENARY SESSION DEBATES
Treatment-induced changes of organ damage predict outcomes
- Yes
R.E. Schmieder (Erlangen, Germany) - More evidence is needed
E. Agabiti Rosei (Brescia, Italy)
Blood pressure targets for treatment: aggressive or conservative?
- Aggressive
M. Burnier (Lausanne, Switzerland) - Conservative
S.E. Kjeldsen (Oslo, Norway)
Drug treatment of resistant hypertension
- Antialdosterone agents are the choice
B. Williams (London, United Kingdom) - Other drug strategies are useful
M. Azizi (Paris, France)